×
For best experience we recommend to activate Javascript in your browser.
Recombinant SUMO1 antibody (Alexa Fluor 594)
The Rabbit Monoclonal anti-SUMO1 antibody has been validated for WB, IHC, IF, FACS, IP and ICC. It is suitable to detect SUMO1 in samples from Human, Rat and Mouse.
Quick Overview for Recombinant SUMO1 antibody (Alexa Fluor 594) (ABIN7781609)
Target
See all SUMO1 Antibodies
SUMO1
(Small Ubiquitin Related Modifier Protein 1 (SUMO1))
Antibody Type
Recombinant Antibody
Reactivity
All reactivities for SUMO1 antibodies
Human, Rat, Mouse
Host
All hosts for SUMO1 antibodies
Rabbit
Clonality
All clonalities for SUMO1 antibodies
Monoclonal
Conjugate
All conjugates for SUMO1 antibodies
This SUMO1 antibody is conjugated to Alexa Fluor 594
Application
All applications for SUMO1 antibodies
Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), Flow Cytometry (FACS), Immunoprecipitation (IP), Immunocytochemistry (ICC)
Product Details anti-SUMO1 Antibody (Alexa Fluor 594)
(hide)
Purpose
Conjugated Sumo 1 Rabbit mAb
Specificity
Sumo 1 Antibody detects endogenous levels of total Sumo 1
Purification
Affinity-chromatography
Immunogen
A synthesized peptide derived from human Sumo 1
Alternatives
(show)
Application Details
(hide)
Application Notes
most applications: 1: 50 - 1: 250
Restrictions
For Research Use only
Handling
(hide)
Buffer
Liquid in PBS, 0.5 % BSA, 40 % Glycerol, 0.02 % Sodium Azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handling Advice
Protect from light!
Storage
4 °C
Storage Comment
Store at 4°C in dark for 6 months
Target Details for SUMO1
(hide)
Target
SUMO1
(Small Ubiquitin Related Modifier Protein 1 (SUMO1))
Alternative Name
Sumo 1
Background
DAP-1, GMP1, OFC10, PIC1, SENP2, SMT3, SMT3C, SMT3H3, SUMO1,UBL1,
UniProt
P63165
Pathways
M Phase , Positive Regulation of Endopeptidase Activity , Protein targeting to Nucleus , Ubiquitin Proteasome Pathway
Recently viewed
(hide)
Chat with us , powered by LiveChat